Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
5.75
-0.15 (-2.54%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Protara Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 308 | 253 | 21 | 30 | 76 | 271 | |
| Market Cap Growth | 61.01% | 1089.52% | -29.43% | -60.18% | -72.06% | - | |
| Enterprise Value | 178 | 177 | -47 | -70 | -55 | 106 | |
| Last Close Price | 5.75 | 5.28 | 1.88 | 2.68 | 6.75 | 24.21 | |
| PB Ratio | 1.68 | 1.52 | 0.31 | 0.30 | 0.47 | 1.36 | |
| P/TBV Ratio | 2.33 | 1.52 | 0.31 | 0.30 | 0.57 | 1.60 | |
| Debt / Equity Ratio | 0.03 | 0.03 | 0.08 | 0.06 | 0.05 | 0.01 | |
| Net Debt / Equity Ratio | -0.98 | -0.99 | -0.88 | -0.94 | -0.76 | -0.84 | |
| Net Debt / EBITDA Ratio | 2.19 | 3.40 | 1.39 | 2.57 | 2.61 | 4.88 | |
| Net Debt / FCF Ratio | 2.66 | 4.62 | 1.60 | 3.61 | 3.52 | 6.90 | |
| Quick Ratio | 13.49 | 15.54 | 10.71 | 14.78 | 21.37 | 57.84 | |
| Current Ratio | 13.69 | 15.71 | 11.17 | 15.01 | 21.66 | 58.13 | |
| Return on Equity (ROE) | -49.42% | -37.88% | -47.44% | -49.96% | -26.17% | -34.48% | |
| Return on Assets (ROA) | -31.30% | -23.59% | -28.36% | -16.42% | -15.80% | -21.07% | |
| Return on Capital Employed (ROCE) | -44.40% | -28.80% | -59.90% | -34.90% | -28.20% | -17.20% | |
| Earnings Yield | -17.17% | -17.59% | -189.67% | -218.41% | -62.30% | -12.52% | |
| FCF Yield | -15.84% | -14.15% | -176.45% | -88.01% | -46.28% | -8.95% | |
| Buyback Yield / Dilution | -129.86% | -81.73% | -0.64% | -0.24% | -55.28% | -180.66% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.